CHRETO ApS: Financial statements 2015
CVR: 33382170
CHRETO ApS (CVR 33382170) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 1,100,204 and a net result of DKK -5,646 compared with DKK 4,711 the year before. That is an increase of 23,253.9% compared with the year before. Equity amounted to DKK 161,497. The solvency ratio was 9.3%.
- Gross Profit
- 1,100,204 kr.
- Profit/Loss
- -5,646 kr.
- Equity
- 161,497 kr.
- Total Assets
- 1,730,545 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 1.1 mio. | -6 t. | 161 t. | - |
| 2014 | - | 5 t. | 5 t. | 167 t. | - |
| 2013 | - | 13 t. | 13 t. | 162 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout CHRETO ApS
CHRETO ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kyhse-Andersen. The company's owners include NOVOZYMES A/S, SKEIKAMPEN INVEST ApS and JAN KYHSE-ANDERSEN HOLDING ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK -2,662,874 and a net result of DKK -3,119,901 compared with DKK -2,336,562 the year before. Equity amounted to DKK 49,010,862.
